2-methoxy-5,6-dimethylpyridine-3-carbonitrile CAS 1926172-50-0
New Products
5-Nitroindazole CAS 5401-94-55-Nitroindazole,5401-94-5,5-Nitro-1H-indazole,C7H5N3O2 […]- Clindamycin EP Impurity J CAS 1309349-64-1Clindamycin EP Impurity J,1309349-64-1,Clindamycin […]
- 2-Amino-4-sulfobenzoic acid CAS 98-43-12-Amino-4-sulfobenzoic acid,98-43-1,4-Sulfoanthranilic acid ; 4-Sulfo-anthranilic acid ; 2-Amino-4-sulfo-benzoic acid,C7H7NO5S […]
- Prezatide copper acetate CAS 130120-57-9Prezatide copper acetate,130120-57-9,,C16H26CuN6O6 […]
- DMT-dG(IPAc) Phosphoramidite CAS UENA-0216Identification […]
- Mesalazine//Mesalamine//5-Aminosalicylic acid(5-ASA) CAS 89-57-6Identification […]
- Lithium Amides CAS 7782-89-0Identification […]
- MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH CAS 1599440-25-1Identification […]
- 4,4’-azodianiline CAS 538-41-0Identification […]
- 5-(Di-tert-butylphosphino)-1′, 3′, 5′-triphenyl-1’H-[1,4′]bipyrazole CAS 894086-00-1BIPPYPHOS,894086-00-1,5-[BIS(TERT-BUTYL)PHOSPHINO]-1',3',5'-TRIPHENYL-1,4'-BI-1H-PYRAZOLE;5-(DI-TERT-BUTYLPHOSPHINO)-1', 3', 5'-TRIPHENYL-1'H-[1,4']BIPYRAZOLE;5-(Di-t-butylphosphino)-1',3',5'-triphenyl-1,4'-bi-1H-pyrazole, min. 95% t-Bu-BippyPhos;5-(Di-t-butylphosphino)-1',3',5'-triphenyl-1,4'-bi-1H-pyrazole;95% t-Bu-BippyPhos;5-[Di(tert-butyl)phosphino]-1',3',5'-triphenyl-1'H-[1,4']bipyrazolyl;5-(Di-t-butylphosphino)-1-(1,3,5-triphenyl-1H-pyrazol-4-yl)-1H-pyrazole, 98% (BippyPhos) […]
![Structure of 5-(Di-tert-butylphosphino)-1', 3', 5'-triphenyl-1'H-[1,4']bipyrazole CAS 894086-00-1](https://www.watson-int.com/wp-content/uploads/2015/05/Structure-of-5-Di-tert-butylphosphino-1-3-5-triphenyl-1H-14bipyrazole-CAS-894086-00-1.gif "Structure of 5-(Di-tert-butylphosphino)-1′, 3′, 5′-triphenyl-1’H-[1,4′]bipyrazole <span class=\"caps\">CAS</span> 894086-00-1")
© 2026 WATSON INTERNATIONAL LIMITED. All Rights Reserved. This site and all content are protected by international Copyright laws. Third party logos and marks appearing on this website are trademarks and/or registered trademarks of their respective owners and licensors, and all rights therein and thereto are reserved to such entities.